OCULID
Oculid offers advanced eye tracking technology for smartphones. We provide an easy and remote testing solution for market and UX research teams to measure visual attention and engagement. Our platform allows you to test digital products, ad campaigns and packaging on mobile phones using the selfie camera. Our data analysis shows how a design performs and which design elements can be optimized. Oculidโs testing platform is easy to use, remote and reliable. It allows research teams to conduct studies anywhere in the world, directly on participants' mobile devices at the comfort of their home, and get in-lab quality insights at a fraction of the cost.
OCULID
Industry:
Consumer Research Human Computer Interaction Market Research Software UX Design
Founded:
2018-04-10
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.oculid.com
Total Employee:
11+
Status:
Active
Contact:
+49 30 28619787
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Euro JsDelivr Cloudflare JS CDN JS AJAX Libraries API
Similar Organizations
Twentify
Twentify is a consumer research platform that allows companies to conduct market research quickly and directly with target consumer base.
Current Employees Featured
Founder
Investors List
IBB Ventures
IBB Ventures investment in Seed Round - Oculid
Newest Events participated
Official Site Inspections
http://www.oculid.com Semrush global rank: 5.75 M Semrush visits lastest month: 1.45 K
- Host name: w8f.rzone.de
- IP address: 81.169.145.95
- Location: Berlin Germany
- Latitude: 52.5174
- Longitude: 13.3985
- Timezone: Europe/Berlin
- Postal: 12529
More informations about "Oculid"
Meta Developers - Oculus VR
Manage your organization. Create your organization. Add financial settings. Get financial reports. Verify your org. Manage multiple orgs. Manage test users. Business models and strategy. โฆSee details»
Authenticate | Build with Meta Horizon OS - Oculus Developer โฆ
Log in to the Meta Quest dashboard to continue. Log in. Build with Meta. Social Technologies. Meta Horizon. AI. Horizon WorldsSee details»
Sign Up | Create new account - Oculus VR
Signing up for a Meta account through the developer website gives you access to develop, test and publish your app on the Meta Horizon Platform. Here are some key things to know.See details»
Oculus
Log in to access the Oculus Developer Dashboard and manage your apps.See details»
Meta Developers - Oculus VR
Inspire your next project with showcases from around the developer community. Find examples of projects expanding the limits of what can be achieved in mixed reality and VR and learn how โฆSee details»
Log in - Oculus
MORE META QUEST. Forums. BlogSee details»
Oculus - Crunchbase Company Profile & Funding
Sub-Organization of . Meta . Founded Date Jul 6, 2012; Founders Brendan Iribe, Jack McCauley, Maxwell Planck, Michael Antonov, Mike LeBeau, Nate Mitchell, Palmer Luckey; Operating Status Active; Last Funding Type Equity โฆSee details»
Create New Organization for Oculus development - Reddit
Create New Organization for Oculus development - What legal name to use? Hey I'm setting up my Quest for development and going to try to submit an app idea eventually. But Oculus asks โฆSee details»
Oculid - Crunchbase Company Profile & Funding
Oculid offers advanced eye tracking technology for smartphones. We provide an easy and remote testing solution for market and UX research teams to measure visual attention and engagement.See details»
Oculis - Crunchbase Company Profile & Funding
The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow โฆSee details»
Oculis
Oculis Reports Q3 2024 Financial Results and Provides Company Updates. Read More. Oct 21 . Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program โฆSee details»
Meet Our Team - Oculis
We are a global biopharmaceutical company purposefully driven to save sight and improve eye care. Led by an experienced management team and supported by leading investors and โฆSee details»
Oculis Provides Updates at R&D Day on Late-Stage Clinical Trials โฆ
Feb 28, 2024 Completed enrollment in Phase 2b RELIEF trial of Licaminlimab (OCS-02), anti-TNF (tumor necrosis factor) alpha eye drops in Dry Eye Disease (DED); topline results โฆSee details»
Oculis Provides Updates at R&D Day on Late-Stage Clinical
Feb 28, 2024 --Oculis Holding AG, a global biopharmaceutical company purposefully driven to save sight and improve eye care, today provides updates at its in-person and virtual R&D Day โฆSee details»
Oculis | Oculis Appoints Dr. Joanne Chang as Global Chief Medical ...
Oct 7, 2024 Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments ... Medical Officer and Vice President of Medical Affairs in Greater โฆSee details»
Oculis Reports Q3 2023 Financial Results and Provides Company โฆ
Nov 15, 2023 ZUG, Switzerland and BOSTON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (โOculisโ or the โCompanyโ), a global biopharmaceutical company โฆSee details»
Oculus
MORE META QUEST. Forums. BlogSee details»
Oculis: Vision for a Paradigm Shift in Ophthalmology Delivery
Aug 11, 2021 Oculisโ second asset, OCS-02, is currently in Phase II. This is a first-in-class anti-TNFฮฑ antibody in-licenced from Novartis, and based on a proprietary single-chain antibody โฆSee details»
Rethinking Ophthalmology - Oculis
Aug 8, 2023 Oculis announces positive top line results from DIAMOND Stage 1 phase 3 trial in diabetic macular edema with OCS-01 eye drops. .May 22, 2023. 3. Shulman S, et al. Acta โฆSee details»
Oculis | Investors and Media
Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) purposefully driven to save sight and improve eye care. Oculisโ highly differentiated pipeline comprises multiple โฆSee details»